维普中文期刊产品整合服务
意见 帮助
基本检索 作者索引 机构索引 期刊索引
  • 哲学宗教
  • 社会学
  • 政治法律
  • 军事
  • 经济管理
  • 文化科学
  • 语言文字
  • 文学
  • 艺术
  • 历史地理
  • 自然科学总论
  • 理学
  • 天文地球
  • 生物学
  • 医药卫生
  • 农业科学
  • 一般工业技术
  • 矿业工程
  • 石油与天然气工程
  • 冶金工程
  • 金属学及工艺
  • 机械工程
  • 兵器科学与技术
  • 动力工程及工程热...
  • 核科学技术
  • 电气工程
  • 电子电信
  • 自动化与计算机技术
  • 化学工程
  • 轻工技术与工程
  • 建筑科学
  • 水利工程
  • 交通运输工程
  • 航空宇航科学技术
  • 环境科学与工程
时间 1989 - 2010 学科选择学科
题名/关键词 模糊
与 题名/关键词 模糊
重新搜索 在结果中搜索
18篇 您的检索式：作者名="Bitossi"
选中 清除  导出 查看参考文献 查看引证文献 引用追踪 共1页 首页 上一页 第1页 下一页 末页 /1 跳转
    题名 作者 年代 出处 被引量
1Incidence of skeletalcomplications in patients with bone metastatic prostate cancerand hormone refractory disease: predictive role of boneresorption and formation markers evaluated at baseline 显示文摘Berruti A Dogliotti L Bitossi R 2000JUrol2000，164，4：1
2Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients显示文摘Tampellini M Berruti A Bitossi R 2006Breast Cancer Res Treat2006，98，3：1
3Six-year stabilisation of a relapsed pelvic mass from rectal cancer after oxaliplatin-containing chemotherapy 显示文摘Tampellini M Brizzi MP Bitossi R 2007J Cancer Res Clin Oncol2007，133，10：1
4Incidence of skeletal complications in patients with bone metastatic prostate cancer and hormone refractory disease: predictive role of bone resorption and formation markers evaluated at baseline显示文摘Berruti A Dogliotti L Bitossi R 2000J Urol2000，164，：1
5Gemeitabine and protracted 5-fluorouracil infusion as third-line chemothera- py in refractory colorectal cancer patients 显示文摘Bitossi tl Sculli CM Tampellini M el al 2008Anticancer Res2008，28，5：1
6Incidence of skeletal complications in patients with bone metastastic prostate cancer and hormone refractory disease:predictive role of bone resorption and formation markers evaluated at baseline显示文摘Berruti A Dogliotti L Bitossi R 2000J Urol2000，164，：1
7Incidence of skeletal compli- cations in patients with bone metastatic prostate cancer and hor- mone refractory disease:predictive role of bone resorption and for- marion markers evaluated at baseline 显示文摘Berruti A Doqliotti L Bitossi R 2000J Uml2000，164，4：1
8Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer: a cost-minimization study 显示文摘Tampellini M Bitossi R Brizzi MP 2004Tumori2004，90，1：1
9Non-invasive tissue Doppler imaging pulmonary capillary wedge pressure measurement improves NT-proBNP prognostic value in heart failure显示文摘Berni A Cappelli F Bitossi L 2009Acta Cardiol2009，64，2：1
10Gemcitabine and pro- tracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients显示文摘Bitossi R Sculli CM Tampellini M 2008Anticancer Res2008，28，5：1
11Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients显示文摘Bitossi R Sculli CM Tampellini M 2008Anticancer Res2008，28，5：1
12Paclitaxel,vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines显示文摘Berruti A Bitossi R Gorzegnn G 2005Br J Cancer2005，92，：1
13Gemcitabine and protracted 5-fluorouracil infusion as third-line chemotherapy in refractory colorectal cancer patients显示文摘Bitossi R Sculli CM Tampellini M 2008Anticancer Res2008，28，5：1
14Incidence of skeletal complications in patients with bone metastastic prostate cancer and hormone refractory disease : predictive role of bone resorption and formation markers evaluated at baseline 显示文摘Berruti A Dogliotti L Bitossi R 2000J Urol2000，164，：1
15Incidence of skeletal complications in patients with bone metastatic prostate Cancer and hormone refractory disease:predictive role of bone resorption and formation markers evaluated at baseline显示文摘Berruti A Dogliotti L Bitossi R 2000J Urol2000，164，：1
16Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine:final results of a phaseⅢstudy with a factorial design显示文摘Berruti A Bitossi R Gorzegno G 2002J Clin Oncol2002，20，20：1
17Pharmacoeconomiccomparison between chronochemotherapy and FOLFOX regimenin the treatment of patients with metastatic gastric cancer: acost2minimization study显示文摘Tampellini M Bitossi R Brizzi MP 2004Tumori2004，90，1：1
18Pharmacoeconomic comparison between chronochemotherapy and FOLFOX regimen in the treatment of patients with metastatic colorectal cancer:a cost-minimization study显示文摘Tampellini M Bitossi R Brizzi MP 0，，01：1
返回顶部 每页显示：
共1页 首页 上一页 第1页 下一页 末页 /1 跳转
goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费